THCA and Delta-8 After the Hemp Ban: What Retailers Must Change

The hemp industry faces one of its most significant regulatory changes since the 2018 Farm Bill. On November 12, 2025, Congress enacted Public Law 119-37, changing the federal hemp framework and narrowing which THCA, Delta-8, and other cannabinoid products can continue qualifying as hemp.

The current effective date is November 12, 2026, unless Congress changes the law. For retailers built around THCA flower, converted cannabinoids, and other intoxicating hemp products, the transition period is already well underway. Product audits, inventory planning, supplier review, and customer communication should therefore happen before the deadline rather than after products lose federal hemp status. A broader compliant growth marketing strategy can also help retailers preserve demand as products and channels change.

Key Takeaways

• November 12, 2026 remains the current federal effective date, unless pending legislation changes the timeline
• The revised plant-level hemp definition uses total THC, including THCA, substantially affecting high-THCA flower
• Converted cannabinoids face separate scrutiny because the new law excludes certain naturally occurring cannabinoids synthesized or manufactured outside the cannabis plant
• State enforcement is already active in several markets, including actions involving intoxicating hemp products in Arizona, Missouri, and Nebraska
• Retailers should focus on product audits, inventory exposure, supplier documentation, compliant alternatives, and customer retention

Understanding the Federal Hemp Change

The 2018 Farm Bill defined hemp primarily around a delta-9 THC threshold. The revised federal law changes that framework by considering total tetrahydrocannabinols, expressly including THCA, when determining whether cannabis plants qualify as hemp.

It also establishes separate restrictions for intermediate and finished hemp-derived cannabinoid products.

Total THC and THCA

The new statute itself does not prescribe a new 0.877 formula. However, USDA’s existing hemp-production testing guidance already accounts for the conversion of THCA into THC.

The USDA hemp FAQ explains total THC for licensed hemp production as:

THCA × 0.877 + delta-9 THC

This conversion factor accounts for the molecular weight lost when THCA converts into THC through decarboxylation.

For example, flower containing 25% THCA and little delta-9 THC would produce a total-THC calculation of roughly 21.9%. Products with THCA concentrations common in the current hemp-flower market would therefore generally exceed the revised 0.3% total-THC plant standard.

The 0.4 mg Per-Container Threshold

The new federal framework also excludes certain final hemp-derived cannabinoid products containing more than 0.4 mg combined total per retail container under the statutory calculation.

This affects more than THCA flower. Gummies, tinctures, vapes, topicals, and other finished cannabinoid products may also need review based on their total contents and manufacturing methods.

What the Change Means for Licensed Dispensaries

State-licensed cannabis dispensaries operate under state cannabis frameworks rather than relying on federal hemp status. Section 781 does not itself eliminate those state programs or revoke state cannabis licenses.

Retailers outside licensed cannabis systems face a different issue. THCA flower or converted cannabinoid products that currently move through ordinary hemp commerce may lose that pathway once they fall outside the revised federal hemp definition.

Products potentially affected include:

• THCA flower sold through hemp retailers
• Delta-8 and other converted cannabinoid products
• Hemp-derived THC gummies and beverages
• Full-spectrum CBD products exceeding applicable thresholds
• Other cannabinoid products relying on the existing federal hemp definition

Retailers considering a move into licensed cannabis should evaluate each state independently because licensing, testing, manufacturing, distribution, and retail requirements differ substantially.

Delta-8 After the Federal Hemp Change

Delta-8 THC requires particularly careful review because commercially concentrated Delta-8 is commonly created by converting hemp-derived CBD.

The new federal law excludes certain products containing cannabinoids that are capable of occurring naturally in cannabis but were synthesized or manufactured outside the plant. It also excludes cannabinoids that cannot naturally be produced by Cannabis sativa L.

That does not mean every product labeled “Delta-8” automatically has the same legal status. Retailers need to understand:

• The cannabinoid's source
• How it was manufactured
• Total cannabinoid content
• Finished-container THC content
• Applicable state restrictions

The manufacturing process matters as much as the product name.

Texas

Texas already regulates parts of the cannabinoid retail market independently of the new federal law. Effective September 1, 2025, Senate Bill 2024 expanded restrictions on e-cigarette products to cover products containing or marketed as containing cannabinoids.

Texas also adopted additional age-verification and hemp-product measures following Executive Order GA-56. Retailers should therefore evaluate Texas-specific product and format rules rather than treating the federal hemp standard as the only requirement.

Wisconsin

Wisconsin currently remains more permissive toward hemp-derived cannabinoid commerce than many states, although its rules continue to evolve. The state definition of hemp remains tied to federal THC limits, and Wisconsin has not adopted a blanket statewide prohibition specifically targeting all Delta-8 products.

Beginning in 2026, however, Wisconsin also introduced a vaping-device directory that affects certain hemp-containing electronic vaping devices. More importantly, state permissiveness will not preserve federal hemp status for products that fall outside the new federal definition after the effective date.

THCA Flower Under the Total-THC Standard

THCA is the acidic precursor to delta-9 THC found naturally in cannabis. When exposed to heat through smoking, vaping, or cooking, THCA undergoes decarboxylation and converts into THC.

That chemistry is why USDA production testing already accounts for THCA's conversion potential. High-THCA flower that qualified for some commercial channels under delta-9-focused interpretations faces a much narrower pathway once the federal definition expressly incorporates total THC.

Retailers should avoid treating all THCA products as automatically identical, but high-potency THCA flower should receive immediate compliance review.

Possible pathways include:

• Transitioning eligible products into state-licensed cannabis channels
• Shifting toward compliant CBD or other cannabinoid products
• Expanding into non-cannabinoid categories
• Reducing exposure to smokable hemp products
• Exiting affected product categories

State Enforcement Is Already Active

Retailers should not assume that all enforcement begins on November 12.

For example, the Arizona Attorney General has stated that unlicensed sales of THC-infused edible products violate Arizona law and has specifically addressed Delta-8 and other hemp-synthesized intoxicants.

In March 2026, the Missouri Attorney General issued a cease-and-desist letter involving allegedly unlawful intoxicating hemp sales, labeling, and contaminants. Nebraska has also conducted retailer investigations and issued cease-and-desist letters involving synthetic THC products and allegedly inaccurate product labeling.

The lesson for retailers is that federal preparation does not replace state compliance. Enforcement exposure can already exist under current state product, cannabis, consumer-protection, or labeling laws.

Retailer Checklist: What to Change Before November 12

The remaining transition period should focus on actions that directly reduce product and inventory exposure.

Audit Products Now

• Test relevant products for total THC and THCA where applicable
• Identify products exceeding the 0.4 mg finished-container threshold
• Document how converted cannabinoids are manufactured
• Match each SKU with current batch-specific COAs
• Separate products requiring federal review from those already restricted by state law

Review Inventory and Suppliers

• Calculate inventory exposure for affected products
• Review return and buyback provisions
• Reduce unnecessary purchases of high-risk SKUs
• Confirm supplier testing and manufacturing documentation
• Review indemnification and change-of-law provisions
• Identify alternative suppliers and compliant categories

Update Operations Before the Deadline

• Establish inventory disposition plans
• Update testing requirements for replacement products
• Review websites, catalogs, and distributor materials
• Prepare customer communication for discontinued or reformulated SKUs
• Verify banking, insurance, fulfillment, and payment-provider requirements

Compliance costs vary widely depending on SKU count, inventory levels, testing needs, contracts, and whether the retailer changes business models. Retailers should model their own exposure rather than relying on generalized cost estimates.

Marketing THCA and Delta-8 During the Transition

Marketing should change alongside product compliance decisions. Retailers should not remove lawful products prematurely simply because federal rules are scheduled to change, but claims need to remain accurate throughout the transition.

Review language such as:

• “Federally legal”
• “Farm Bill compliant”
• “Legal in all 50 states”
• “Ships anywhere”
• Broad claims about future availability

Marketing also needs to reflect state-specific restrictions. A product may remain available in one jurisdiction while requiring different treatment elsewhere.

A full-funnel performance marketing approach can help retailers connect acquisition, customer education, first-party audience development, retargeting, and retention rather than depending on one restricted advertising channel. Retailers changing their product mix can also evaluate regulated marketing services across paid media, SEO, email, content, analytics, and first-party data as customer demand shifts.

Building Consumer Trust Through Testing and Transparency

As products change, clear documentation becomes increasingly important.

Retailers should consider:

• Batch-specific COAs
• Clear cannabinoid disclosures
• Accessible ingredient information
• Supplier documentation
• Appropriate age controls
• Accurate product descriptions
• Transparent communication when formulations change

USDA encourages laboratories involved in hemp production testing to follow strong quality practices, although its current laboratory guidance does not require every testing laboratory to hold ISO 17025 accreditation.

Retailers should therefore avoid claiming ISO certification is universally federally mandated unless a specific state, contract, or product program requires it.

Customer acquisition and retention programs also need appropriate handling of personal information. Businesses building first-party audiences should maintain clear consent and data practices and can review Herb's privacy policy for how its websites and services address the collection, use, and disclosure of information.

Diversifying Beyond THCA and Delta-8

Retailers heavily dependent on intoxicating hemp products may need to broaden their product mix.

Potential categories include:

• CBD isolate products
• Broad-spectrum products that satisfy applicable thresholds
• Eligible CBG, CBN, or other cannabinoid formulations
• Non-cannabinoid functional products
• Industrial-hemp products
• State-licensed cannabis products where the retailer has an appropriate pathway

Each category still requires its own regulatory analysis. “Non-intoxicating” should not be treated as synonymous with “automatically compliant.”

The strongest transition strategy depends on the retailer's existing audience, product mix, geography, supplier relationships, and capital requirements.

Could Congress Still Change the Federal Rules?

Yes. Several bills introduced during the 119th Congress would delay, repeal, or replace portions of Section 781.

Relevant proposals include:

• American Hemp Protection Act (H.R. 6209): Would repeal Section 781
• Hemp Planting Predictability Act (H.R. 7024/S. 3686): Would extend the implementation period from one year to three years
• Hemp Enforcement, Modernization, and Protection Act (H.R. 7212): Proposes federal regulation of cannabinoid hemp products
• Cannabinoid Safety and Regulation Act (S. 3474): Proposes an FDA-centered cannabinoid regulatory framework
• Lawful Hemp Protection Act (H.R. 9830): Proposes a different federal framework intended to preserve lawful hemp commerce while regulating higher-risk products

The Senate also passed H.R. 6500 on August 8, 2026 with a provision that would delay most Section 781 changes until December 11, 2026. That Senate-amended measure has not completed the legislative process.

Retailers should therefore monitor Congress while continuing to plan around November 12, 2026 under current law.

Keeping Retail Customers Through the THCA and Delta-8 Transition

The product transition also creates a customer-retention challenge. A retailer may lose access to a popular THCA or Delta-8 SKU without necessarily losing the customer who purchased it.

Key priorities include:

• Audience development to maintain direct, consent-based customer relationships
• Product education explaining what is changing and which alternatives remain available
• Email retention for launches, availability updates, and replacement products
• Retargeting for customers who show purchase intent but do not convert
• SEO and content to answer changing legality and product questions
• Performance tracking to understand which replacement categories retain demand

Retailers using customer accounts, website services, or other digital tools should also make sure customer-facing policies remain current. Herb Agency publishes its own terms of service covering access to and use of its websites and services.

A connected set of marketing services can support paid media, SEO, email, first-party data, editorial content, direct mail, social, reactivation, analytics, and UGC measurement. Herb Mail can support consent-based audience development, Herb Reactivate can help maintain existing email reach, and Herb Postal creates another retargeting touchpoint for cart abandoners.

Retailers can also review client testimonials for Herb Agency-reported results across audience development, content, acquisition, and retention campaigns. Businesses developing a transition plan can build a customized roadmap around their product mix, customer base, and November deadline.

Frequently Asked Questions

Will the federal hemp rules actually be enforced?

The level and form of future federal enforcement cannot be predicted with certainty. The new law changes which products qualify as hemp, while states can separately enforce their own cannabis, hemp, consumer-protection, labeling, and retail laws. Retailers should therefore plan around the statutory requirements rather than assuming enforcement will be minimal. Existing state actions involving intoxicating hemp products also show that compliance exposure does not depend entirely on future federal enforcement.

What happens to existing THCA flower and Delta-8 inventory after November 12, 2026?

Section 781 does not provide a broad grandfather provision guaranteeing that products outside the revised hemp definition can remain in ordinary hemp commerce. Retailers should identify potentially affected inventory and develop disposition plans before the effective date. Options may depend on contracts, state law, product composition, and whether another lawful regulated pathway exists. Retailers should obtain product-specific legal guidance before continuing sales or interstate shipment after the rules change.

How might banks and payment processors respond?

Banks and payment processors set their own risk and eligibility policies, so retailers should not assume that every provider will follow the same timetable. Some may review merchants or individual product categories before November 12, while others may wait for additional regulatory guidance. Retailers should communicate with existing providers and maintain product and compliance documentation that can support account reviews. Any backup provider should be evaluated based on lawful product eligibility rather than treated as a workaround.

Can Delta-8 gummies be reformulated to comply with the 0.4 mg cap?

A finished product can potentially be formulated below the applicable threshold, but the 0.4 mg limit is not the only issue for Delta-8. The revised law also addresses cannabinoids that are synthesized or manufactured outside the cannabis plant, making the production method relevant to federal hemp status. A dramatically lower cannabinoid dose may also change the commercial purpose and customer expectation of the product. Retailers and manufacturers should evaluate composition, manufacturing method, and market demand together.

How can retailers transition THCA products into licensed cannabis markets?

Moving into state-licensed cannabis requires compliance with the particular state's cannabis framework rather than simply relabeling a hemp product. Depending on the jurisdiction, that may involve licensing, approved manufacturing, testing, inventory tracking, packaging, distribution, security, and retail requirements. Cannabis products also generally cannot move between state markets through ordinary interstate commerce. Retailers considering this pathway should evaluate licensing availability and economics separately in each state.